Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced a poster presentation related to the ...
Potent antibacterial activity against Gram-negative community and hospital-acquired infections highlighted across eight posters and two presentationSEDMONTON, Alberta , April 19, 2026 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results